Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

This study has been terminated.
(Reactogenicity met study halting criteria)
Sponsor:
Collaborator:
PATH
Information provided by (Responsible Party):
Karen Kotloff, MD, University of Maryland
ClinicalTrials.gov Identifier:
NCT00866476
First received: March 19, 2009
Last updated: January 16, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)